|Systematic (IUPAC) name|
|Pregnancy cat.||C (AU)|
|Legal status||Prescription Only (S4) (AU) POM (UK)|
|Metabolism||Hepatic (minimal; most excreted unchanged)|
|Excretion||Renal (23-46%), Faecal|
|Mol. mass||369.48 g/mol|
|(what is this?)|
Amisulpride (sold as Amazeo, Amipride (AU), Amival, Solian (AU, IE, UK, ZA), Soltus, Sulpitac (IN), Sulprix (AU)), is an atypical antipsychotic used to treat psychosis in schizophrenia and episodes of mania in bipolar disorder. In Italy, it is also used as a treatment for dysthymia.
It was introduced by Sanofi-Aventis in the 1990s. Its patent had expired by 2008 and hence generic formulations are now available.